Overview
Rare cancers account for 20 per cent of cancers diagnosed in Australia, and 30 per cent of cancer-related deaths. People with rare cancers are more likely to die from their disease than people with more common cancers.
The outlook for people with rare cancers is not as good as that for people with more common cancers because:
- Rare cancers are often diagnosed at late, more advanced and harder to treat stages, because there are no effective screening strategies For patients and their health professionals may not recognise the symptoms of rare cancers
- Treatments for many rare cancers have not advanced at the same pace as treatments for more common cancers in recent years. This is because it is much harder to research or perform clinical trials for rarer diseases and there is often less support for researchers or clinicians.
The COSA Rare Cancers Group was established to help support and improve outcomes for patients with rare cancers. We work with community support groups such as Rare Cancers Australia (rarecancers.org.au) and the Cancer Council's Rare and Less Common Cancers Working Group.
We take an Australia-wide and international approach as collaborations are vital to more rapidly develop rare cancer knowledge and provide the most robust evidence-based for rare cancer patients.
Our membership is open to allied health and medical practitioners, and cancer researchers, with an interest in rare cancers. We also work with other tumour stream specialty groups to promote and develop rare cancer trials and research.
Group information
Read the Rare Cancers Group Terms of Reference
Read the AGM Minutes from 7 December 2020
What’s the latest
Group Chair

Group Chair
Clare Scott
Rare Cancers Group Chair & ANZGOG Representative
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 9 hours ago
RT by @COSAoncology: We can't thank enough all those who helped our team locally: @HNEHealth @UON_research Calvary Mater Newcastle, all our…
Read More >
COSAoncology 10 hours ago
RT by @COSAoncology: Data from recent #cancersurvivorship symposium. We need tools (https://t.co/9CokjAtani) to extend basic psychological c…
Read More >
COSAoncology 3 days ago
RT by @COSAoncology: 🚨1 week left🚨 to submit your expressions of interest to join the @COSAoncology Survivorship Executive Committee. EOI’s…
Read More >
COSAoncology 4 days ago
RT by @COSAoncology: Dr Robyn Brennen’s Clinical Oncology Society of Australia (COSA) poster #2: Adjuvant therapy was associated with increase…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Such an important area of research and applies all over the world. Huge disparities for Australia's First Peoples as wel…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Great opportunity to make a difference in the lives of people with Head & Neck Cancer. #HNCSM #PHD @hncanceraus @Sydney_Uni @Us…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: .@Sabesan68 @profevasegelov @jrzalcberg @COSAoncology @VCCCAlliance @RtnVic @awrccentre @MOGA_ORG #dct
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Hybrid #decentralized #clinicaltrials and #telehealth to improve patient access to trials are coming 💊 Site, sponsor and r…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Our @COSAoncology Survivorship Executive Committee is seeking expressions of interest for new members. If you’re a COSA…
Read More >